Africa: Why Some People Got Blood Clots After the Astrazeneca Vaccine - New Clues

[The Conversation Africa] AstraZeneca in partnership with the University of Oxford developed one of the first vaccines against COVID. The vaccine, which used an adenovirus to smuggle instructions into human cells to make antibodies against the novel coronavirus, saved countless lives. But a problem soon emerged. A tiny proportion - about one in 50,000 - of those vaccinated developed blood clots.